Torrent Pharma Is Competing To Acquire Hamied Family’s Cipla Shares; Details

According to persons with knowledge of the situation, Torrent Pharma has joined the competition to buy the Hamied family’s interest in Cipla. The fourth-ranked pharmaceutical firm is valued at more than twice (2.3x) its FY23 consolidated sales, 2.3 times its profit, and 1.46 times its current market value. Ahmedabad-based Torrent wants to acquire control of it.

However, Blackstone, the biggest buyout firm, and Baring PE Asia-EQT are also in the running to acquire the Hamied family’s share in Cipla. JP Morgan is providing advice to Torrent Pharma as it considers the pros and drawbacks of joining a partnership with private equity investors. It has been stated that preliminary negotiations in this respect have already occurred with a few possible partners.